References
- KlaassenIVan NoordenCJSchlingemannROMolecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditionsProg Retin Eye Res201334194823416119
- AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
- WeisSMChereshDAPathophysiological consequences of VEGF-induced vascular permeabilityNature200543749750416177780
- DejanaETournier-LasserveEWeinsteinBMThe control of vascular integrity by endothelial cell junctions: molecular basis and pathological implicationsDev Cell20091620922119217423
- HoACScottIUKimSJAnti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of OphthalmologyOphthalmology20121192179218822917890
- RovielloGRavelliAPolomKApatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancerCancer Lett201637218719126797419
- TianSQuanHXieCYN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivoCancer Sci20111021374138021443688
- LiJQinSXuJApatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJ Clin Oncol2013313219322523918952
- LiJZhaoXChenLSafety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignanciesBMC Cancer20101052920923544
- KimJYChoiJSSongSHStem cell factor is a potent endothelial permeability factorArterioscler Thromb Vasc Biol2014341459146724790137
- KompellaUBAmriteACPacha RaviRDurazoSANanomedicines for back of the eye drug delivery, gene delivery, and imagingProg Retin Eye Res20133617219823603534
- DieboldYCalongeMApplications of nanoparticles in ophthalmologyProg Retin Eye Res20102959660920826225
- XuQKambhampatiSPKannanRMNanotechnology approaches for ocular drug deliveryMiddle East Afr J Ophthalmol201320263723580849
- Kragh-HansenUChuangVTOtagiriMPractical aspects of the ligand-binding and enzymatic properties of human serum albuminBiol Pharm Bull20022569570412081132
- SparreboomAScriptureCDTrieuVComparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)Clin Cancer Res2005114136414315930349